Jun 4 |
Sector Update: Health Care Stocks Rise Tuesday Afternoon
|
Jun 4 |
Amarin falls on CEO exit and Vascepa coverage update
|
Jun 4 |
Amarin names Aaron Berg as CEO
|
Jun 4 |
Amarin Board of Directors Announces CEO Transition
|
May 28 |
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.
|
May 6 |
Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
|
May 3 |
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript
|
May 3 |
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
|
May 2 |
Amarin First Quarter 2024 Earnings: EPS Beats Expectations
|
May 1 |
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
|